Table 1.
Stem cell assay | Expected outcome | Caveat | Alternative outcomes |
---|---|---|---|
Expression of stem cell markers | Cells expressing stem cell markers found in other tissues are considered stem cells | No universal marker for stem cells is known | Stem cell marker expression is not always limited to stem cells |
Morphology and localization | Proliferating intercalated duct cells located in appropriate proximity to acini are designated as stem cells | Static analysis of cell proximity does not demonstrate a lineage relationship | Rapid division of duct cells generates only duct cells |
Label-retaining assay | LRCs are slow cycling stem cells | Label can also be retained by postmitotic cells | LRCs can be long-lived terminally differentiated cells |
In vitro proliferation | In vitro proliferation for more than one passage is an exclusive capability of stem cells |
|
Rapidly dividing and expanding cells may be an in vitro artifact |
In vitro differentiation potential | Evidence of acinar, ductal, and myoepithelial markers or morphology indicates differentiation of a stem cell |
|
|
Sphere formation | The formation of spheres in culture is evidence of stem cell activity |
|
Cells aggregated into spheres can include differentiated cells from original dissociation, and dividing cells that may not be stem cells |
Transplantation | Rescue of salivary gland function by transplanted cells is due to regeneration by stem cells |
|
Rescue of salivary gland function may be due to paracrine activity of injected cells |
In vivo lineage tracing | Tracing a multipotent stem cell lineage should produce acinar, duct, and even myoepithelial cells | Cell labeling is based on the promoter chosen to drive Cre, which may be dynamically regulated or expressed in multiple cell types | Lineage tracing shows that acinar and duct cells are lineage restricted, except under conditions of extreme injury |
Abbreviation: LRCs, label retaining cells.